Oral Lenalidomide and Intravesical BCG for Therapy of Bladder Cancer

NCT01373294 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: Bacille Calmette-Guerrin (BCG)
DRUG: Lenalidomide

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]